Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Alpha Teknova
TKNO
$396M
| $2M | ﹤0.01% |
+80,483
| New | +$1.72M |
|
|
FNCH
3352
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
| $2M | ﹤0.01% |
5,118
+434
| +9% | +$185K |
|
3353
Cognyte Software
CGNT
$692M
| $1.99M | ﹤0.01% |
96,933
-1,549
| -2% | -$39.6K |
|
|
PFSW
3354
DELISTED
PFSweb, Inc.
PFSW
| $1.99M | ﹤0.01% |
154,084
+19,174
| +14% | +$240K |
|
|
CGC
3355
Canopy Growth
CGC
$426M
| $1.99M | ﹤0.01% |
14,115
+3,803
| +37% | +$681K |
|
3356
National Bankshares
NKSH
$272M
| $1.98M | ﹤0.01% |
54,536
+350
| +0.6% | +$12.8K |
|
3357
Neuronetics
STIM
$211M
| $1.98M | ﹤0.01% |
301,893
-75,707
| -20% | -$726K |
|
3358
Blend Labs
BLND
$367M
| $1.97M | ﹤0.01% |
+146,148
| New | +$2.48M |
|
|
CEI
3359
DELISTED
Camber Energy, Inc
CEI
| $1.96M | ﹤0.01% |
10,252
+6,937
| +209% | +$312K |
|
3360
Farmers & Merchants Bancorp
FMAO
$486M
| $1.96M | ﹤0.01% |
87,351
+1,516
| +2% | +$33.9K |
|
3361
iShares Core S&P 500 ETF
IVV
$910B
| – | – |
0
| – | – |
|
|
RAIN
3362
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $1.94M | ﹤0.01% |
129,951
+2,233
| +2% | +$38.1K |
|
|
CTIC
3363
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $1.94M | ﹤0.01% |
658,826
+69,676
| +12% | +$190K |
|
|
GRFS
3364
Grifois
GRFS
$5.4B
| $1.93M | ﹤0.01% |
132,438
-22,925
| -15% | -$347K |
|
3365
LCNB Corp
LCNB
$285M
| $1.93M | ﹤0.01% |
109,614
-12
| -0% | -$205 |
|
3366
BayCom
BCML
$339M
| $1.93M | ﹤0.01% |
103,593
-12
| -0% | -$215 |
|
|
RSVR
3367
Reservoir Media
RSVR
$656M
| $1.93M | ﹤0.01% |
211,408
+201,039
| +1,939% | +$1.77M |
|
3368
Disc Medicine
IRON
$3.07B
| $1.91M | ﹤0.01% |
15,791
+651
| +4% | +$89K |
|
3369
Build-A-Bear
BBW
$474M
| $1.91M | ﹤0.01% |
112,499
+1,839
| +2% | +$30.1K |
|
|
TLIS
3370
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $1.89M | ﹤0.01% |
20,198
+2,995
| +17% | +$399K |
|
3371
Target Hospitality
TH
$1.62B
| $1.89M | ﹤0.01% |
507,438
-4,645
| -0.9% | -$17.1K |
|
3372
FVCBankcorp
FVCB
$339M
| $1.88M | ﹤0.01% |
117,770
+2,539
| +2% | +$39K |
|
3373
NextDecade
NEXT
$1.8B
| $1.88M | ﹤0.01% |
675,562
-376,176
| -36% | -$1.19M |
|
3374
Spok Holdings
SPOK
$230M
| $1.87M | ﹤0.01% |
183,209
-1,586
| -0.9% | -$14.2K |
|
3375
Western New England Bancorp
WNEB
$282M
| $1.87M | ﹤0.01% |
219,551
+4,196
| +2% | +$35.1K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.